GSK-3858279

N/A

Report date: 2025/04/25 20:01:23

Base Information

Drug NameGSK-3858279
Drug Alias NameGSK-3858279
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionC-C motif chemokine 17 inhibitors
TargetsC-C motif chemokine 17
Therapy Area/IndicationsPainDiabetic NeuropathiesOsteoarthritis, Knee +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[15] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGlaxosmithkline Plc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGlaxosmithkline Trading Services LtdGlaxosmithkline (China) Investment Co Ltd
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsPainDiabetic Neuropathies
Inactive IndicationsOsteoarthritis, KneeOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A